Cargando…

CRISPR: A new paradigm of theranostics

Infectious and hereditary diseases are the primary cause of human mortality globally. Applications of conventional techniques require significant improvement in sensitivity and specificity in therapeutics. However, clustered regularly interspaced short palindromic repeats (CRISPRs) is an innovative...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Neelam, Narang, Jagriti, Chhillar, Anil Kumar, Rana, Jogender Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831819/
https://www.ncbi.nlm.nih.gov/pubmed/33359413
http://dx.doi.org/10.1016/j.nano.2020.102350
_version_ 1783641699295166464
author Yadav, Neelam
Narang, Jagriti
Chhillar, Anil Kumar
Rana, Jogender Singh
author_facet Yadav, Neelam
Narang, Jagriti
Chhillar, Anil Kumar
Rana, Jogender Singh
author_sort Yadav, Neelam
collection PubMed
description Infectious and hereditary diseases are the primary cause of human mortality globally. Applications of conventional techniques require significant improvement in sensitivity and specificity in therapeutics. However, clustered regularly interspaced short palindromic repeats (CRISPRs) is an innovative genome editing technology which has provided a significant therapeutic tool exhibiting high sensitivity, fast and precise investigation of distinct pathogens in an epidemic. CRISPR technology has also facilitated the understanding of the biology and therapeutic mechanism of cancer and several other hereditary diseases. Researchers have used the CRISPR technology as a theranostic approach for a wide range of diseases causing pathogens including distinct bacteria, viruses, fungi and parasites and genetic mutations as well. In this review article, besides various therapeutic applications of infectious and hereditary diseases we have also explained the structure and mechanism of CRISPR tools and role of CRISPR integrated biosensing technology in provoking diagnostic applications.
format Online
Article
Text
id pubmed-7831819
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78318192021-01-26 CRISPR: A new paradigm of theranostics Yadav, Neelam Narang, Jagriti Chhillar, Anil Kumar Rana, Jogender Singh Nanomedicine Original Article Infectious and hereditary diseases are the primary cause of human mortality globally. Applications of conventional techniques require significant improvement in sensitivity and specificity in therapeutics. However, clustered regularly interspaced short palindromic repeats (CRISPRs) is an innovative genome editing technology which has provided a significant therapeutic tool exhibiting high sensitivity, fast and precise investigation of distinct pathogens in an epidemic. CRISPR technology has also facilitated the understanding of the biology and therapeutic mechanism of cancer and several other hereditary diseases. Researchers have used the CRISPR technology as a theranostic approach for a wide range of diseases causing pathogens including distinct bacteria, viruses, fungi and parasites and genetic mutations as well. In this review article, besides various therapeutic applications of infectious and hereditary diseases we have also explained the structure and mechanism of CRISPR tools and role of CRISPR integrated biosensing technology in provoking diagnostic applications. Elsevier Inc. 2021-04 2021-01-09 /pmc/articles/PMC7831819/ /pubmed/33359413 http://dx.doi.org/10.1016/j.nano.2020.102350 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Yadav, Neelam
Narang, Jagriti
Chhillar, Anil Kumar
Rana, Jogender Singh
CRISPR: A new paradigm of theranostics
title CRISPR: A new paradigm of theranostics
title_full CRISPR: A new paradigm of theranostics
title_fullStr CRISPR: A new paradigm of theranostics
title_full_unstemmed CRISPR: A new paradigm of theranostics
title_short CRISPR: A new paradigm of theranostics
title_sort crispr: a new paradigm of theranostics
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831819/
https://www.ncbi.nlm.nih.gov/pubmed/33359413
http://dx.doi.org/10.1016/j.nano.2020.102350
work_keys_str_mv AT yadavneelam crispranewparadigmoftheranostics
AT narangjagriti crispranewparadigmoftheranostics
AT chhillaranilkumar crispranewparadigmoftheranostics
AT ranajogendersingh crispranewparadigmoftheranostics